All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
XS-0822-YF2435 | Anti-Human CD171 (XW-595) h(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-595 | Mouse | scFv-CD28-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF2436 | Anti-Human CD171 (XW-596) h(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-596 | Human | scFv-CD28-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF2437 | Anti-Human CD171 (XW-597) h(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-597 | Mouse | scFv-CD28-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF2438 | Anti-Human CD171 (XW-598) h(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-598 | Mouse | scFv-CD28-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF2439 | Anti-Human CD171 (XW-599) h(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-599 | Mouse | scFv-CD28-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF2440 | Anti-Human CD171 (XW-600) h(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-600 | Human | scFv-CD28-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF2441 | Anti-Mouse CD171 (XW-601) m(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Mouse | XW-601 | Human | scFv-CD28-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF2445 | Anti-Human CD171 (XW-605) h(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-605 | Mouse | scFv-CD28-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF2446 | Anti-Human CD171 (XW-606) h(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-606 | Mouse | scFv-CD28-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF8451 | TS-Fluc Anti-Human CD171 scFv (XW-595) CD28-CD3ζ CAR, pCDCAR1 | Human | XW-595 | Mouse | 7H-YB-Fluc-EF1a-scFv-CD28-CD3ζ | Lentiviral vector | |||
XS-0822-YF8452 | TS-Fluc Anti-Human CD171 scFv (XW-596) CD28-CD3ζ CAR, pCDCAR1 | Human | XW-596 | Human | 7H-YB-Fluc-EF1a-scFv-CD28-CD3ζ | Lentiviral vector | |||
XS-0822-YF8453 | TS-Fluc Anti-Human CD171 scFv (XW-597) CD28-CD3ζ CAR, pCDCAR1 | Human | XW-597 | Mouse | 7H-YB-Fluc-EF1a-scFv-CD28-CD3ζ | Lentiviral vector | |||
XS-0822-YF8454 | TS-Fluc Anti-Human CD171 scFv (XW-598) CD28-CD3ζ CAR, pCDCAR1 | Human | XW-598 | Mouse | 7H-YB-Fluc-EF1a-scFv-CD28-CD3ζ | Lentiviral vector | |||
XS-0822-YF8455 | TS-Fluc Anti-Human CD171 scFv (XW-599) CD28-CD3ζ CAR, pCDCAR1 | Human | XW-599 | Mouse | 7H-YB-Fluc-EF1a-scFv-CD28-CD3ζ | Lentiviral vector | |||
XS-0822-YF8456 | TS-Fluc Anti-Human CD171 scFv (XW-600) CD28-CD3ζ CAR, pCDCAR1 | Human | XW-600 | Human | 7H-YB-Fluc-EF1a-scFv-CD28-CD3ζ | Lentiviral vector | |||
XS-0822-YF8457 | TS-Fluc Anti-Mouse CD171 scFv (XW-601) CD28-CD3ζ CAR, pCDCAR1 | Mouse | XW-601 | Human | 7H-YB-Fluc-EF1a-scFv-CD28-CD3ζ | Lentiviral vector | |||
XS-0822-YF8458 | TS-Fluc Anti-Mouse CD171 scFv (XW-602) CD28-CD3ζ CAR, pCDCAR1 | Mouse | XW-602 | Human | 7H-YB-Fluc-EF1a-scFv-CD28-CD3ζ | Lentiviral vector | |||
XS-0822-YF8860 | TS-Fluc Anti-Human CD171 scFv (XW-595) 41BB-CD3ζ CAR, pCDCAR1 | Human | XW-595 | Mouse | 7H-YB-Fluc-EF1a-scFv-41BB-CD3ζ | Lentiviral vector | |||
XS-0822-YF8861 | TS-Fluc Anti-Human CD171 scFv (XW-596) 41BB-CD3ζ CAR, pCDCAR1 | Human | XW-596 | Human | 7H-YB-Fluc-EF1a-scFv-41BB-CD3ζ | Lentiviral vector | |||
XS-0822-YF8862 | TS-Fluc Anti-Human CD171 scFv (XW-597) 41BB-CD3ζ CAR, pCDCAR1 | Human | XW-597 | Mouse | 7H-YB-Fluc-EF1a-scFv-41BB-CD3ζ | Lentiviral vector | |||
XS-0823-LX11 | Anti-hCD171 (E7) ICD(CD28-OX40-CD3ζ) CAR-MA, pAd5f35 Vector | Human | E7 | Adenoviral vectors |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION